VX-581

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated

Conditions

Cystic Fibrosis

Phase 1

Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants

RecruitingNCT07283770

Vertex Pharmaceuticals IncorporatedCystic Fibrosis

Start: 2025-12-09End: 2026-11-19Target: 136Updated: 2026-07-16

A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation

Not yet recruitingNCT07813039

Vertex Pharmaceuticals IncorporatedCystic Fibrosis

Start: 2026-09-07End: 2026-10-27Target: 16Updated: 2026-09-10